Patents by Inventor Jose Munoz-Olaya

Jose Munoz-Olaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-MESOTHELIN ANTIBODIES
    Publication number: 20220267421
    Abstract: The present application relates to antibody molecules that bind mesothelin (MSLN). The antibody molecules find application in the treatment and diagnosis of diseases and disorders, such as cancer.
    Type: Application
    Filed: July 12, 2019
    Publication date: August 25, 2022
    Applicant: F-star Beta Limited
    Inventors: Jose Munoz-Olaya, Remi Fertin, Francisca Wollerton, Mihriban Tuna, Neil Brewis
  • FC BINDING FRAGMENTS COMPRISING A CD137 ANTIGEN-BINDING SITE
    Publication number: 20220119539
    Abstract: The invention relates to specific binding members that bind CD137. The specific binding members comprise a CD137 antigen-binding site located in a constant domain of the specific binding member and find application in the treatment of cancer and infectious diseases, for example.
    Type: Application
    Filed: July 12, 2019
    Publication date: April 21, 2022
    Applicant: F-star Beta Limited
    Inventors: Matthew Lakins, Jose Munoz-Olaya, Sarka Pechouckova, Mihriban Tuna
  • ANTIBODY MOLECULES THAT BIND PD-L1 AND CD137
    Publication number: 20220049007
    Abstract: The present application relates to antibody molecules that bind both PD-L1 and CD 137 and are able to induce agonism of CD137. The antibody molecules comprise a CDR-based binding site for PD-L1, and a CD137 antigen-binding site that is located in a constant domain of the antibody molecule. The antibody molecules of the invention find application, for example, in the treatment of diseases, such as cancer.
    Type: Application
    Filed: July 12, 2019
    Publication date: February 17, 2022
    Applicant: F-star Beta Limited
    Inventors: Matthew Lakins, Jose Munoz-Olaya, Francisca Wollerton, Sarah Batey, Mihriban Tuna, Alexander Koers
  • MESOTHELIN AND CD137 BINDING MOLECULES
    Publication number: 20210309753
    Abstract: The present invention relates to antibody molecules that bind both mesothelin (MSLN) and CD137. The antibody molecules comprise a CDR-based binding site for MSLN, and a CD137 antigen-binding site located in a constant domain of the antibody molecule. The antibody molecules find application in the treatment of cancer, for example.
    Type: Application
    Filed: July 12, 2019
    Publication date: October 7, 2021
    Applicant: F-star Delta Limited
    Inventors: Jose Munoz-Olaya, Mihriban Tuna, Remi Fertin, Claire Reader, Francisca Wollerton, Neil Brewis
  • FC BINDING FRAGMENTS COMPRISING A CD137 ANTIGEN-BINDING SITE
    Publication number: 20210277134
    Abstract: The invention relates to specific binding members that bind CD137. The specific binding members comprise a CD137 antigen-binding site located in a constant domain of the specific binding member and find application in the treatment of cancer and infectious diseases, for example.
    Type: Application
    Filed: July 12, 2019
    Publication date: September 9, 2021
    Applicant: F-star Beta Limited
    Inventors: Matthew Lakins, Jose Munoz-Olaya, Sarka Pechouckova, Mihriban Tuna